Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer CME Institute Clients Include Kaiser, Veterans Health Administration

Executive Summary

The Bayer Institute for Health Care Communications focuses its continuing medical education activities on enhancing clinician/patient communication.

You may also be interested in...



Industry CME Affiliates Would Be Restricted Under Accrediting Proposal

Continuing medical education providers affiliated with drug manufacturers would be prohibited from conducting CME programs in therapeutic categories where the manufacturer has products under a proposed revision to the Accreditation Council for Continuing Medical Education's standards for providers

Industry CME Affiliates Would Be Restricted Under Accrediting Proposal

Continuing medical education providers affiliated with drug manufacturers would be prohibited from conducting CME programs in therapeutic categories where the manufacturer has products under a proposed revision to the Accreditation Council for Continuing Medical Education's standards for providers

Physicians Must Be “Fiduciary Stewards” To Rein In Rx Costs – Kaiser

Pharmaceutical spending will only come under control if physicians take more responsibility for the financial impact of prescribing decisions, Kaiser Permanente Medical Group Associate Executive Director Sharon Levine, MD, said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel